ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. (CLPT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CLPT · as of Jun 8, 2026
Key Statistics
Explore ClearPoint Neuro, Inc. Data
clpt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 100.0%
The CLPT analyst consensus is Buy, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $18.00, representing +39.64% upside from the current price of $12.89.
Competitors & Peers
clpt competitorsCLPT
AKBA
AVNS
CMPS
CTKB
LABStock Performance
Full HistoryAbout ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in t…
what is clearpoint neuro, inc. · clpt stock overview · clearpoint neuro, inc. company profile · who is clearpoint neuro, inc. ceo · clpt NASDAQ · clearpoint neuro, inc. headquarters · clearpoint neuro, inc. business segments
About Stock Overview & Key Data
ClearPoint Neuro, Inc. (CLPT) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since May 22, 2012. As of the latest trading session, CLPT stock price is $12.89, with a market capitalization of $386.6M. The stock has returned -3.16% over the past 12 months and -5.77% year-to-date.
According to 3 Wall Street analysts, the consensus rating for ClearPoint Neuro, Inc. stock is Buy, with an average 12-month price target of $18.00. In fiscal year 2025, ClearPoint Neuro, Inc. reported revenue of $37.0M and net income of -$25.5M. For detailed data — including ClearPoint Neuro, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, ClearPoint Neuro, Inc. (CLPT) stock price is $12.89. The stock is traded on NASDAQ under the ticker symbol CLPT. The 52-week range is $8.27 – $30.10.